These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3196416)

  • 21. Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants.
    Deffieux X; Morice P; Camatte S; Fourchotte V; Duvillard P; Castaigne D
    Gynecol Oncol; 2005 Apr; 97(1):84-9. PubMed ID: 15790442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: case report.
    Attar E; Berkman S; Topuz S; Baysal B; Akhan S; Chambers JT
    Hum Reprod; 2004 Jun; 19(6):1472-5. PubMed ID: 15105388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gliomatosis peritonei].
    Jo S; Kaku T; Tsukamoto M; Matsuyama T; Matsukuma K; Kamura T; Imachi M
    Gan No Rinsho; 1987 Feb; 33(2):231-5. PubMed ID: 3560455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serous borderline ovarian tumors].
    Zipprich K; Albrecht G; Canzler E
    Zentralbl Gynakol; 1985; 107(3):159-68. PubMed ID: 3984570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
    Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
    Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Borderline epithelial tumours of the ovary--a retrospective analysis of 31 cases.
    Kane SV; Bharadwaj R; Tongaonkar HB
    Indian J Cancer; 1999 Mar; 36(1):18-31. PubMed ID: 10810551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term follow-up of serous and mucinous cystadenocarcinoma and borderline epithelial tumors of the ovary].
    Zhu GZ
    Zhonghua Fu Chan Ke Za Zhi; 1988 Jan; 23(1):35-7, 61. PubMed ID: 3383694
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclooxygenase 2 expression in serous tumors of the ovary.
    Singhal PK; Spiegel G; Driscoll D; Odunsi K; Lele S; Rodabaugh KJ
    Int J Gynecol Pathol; 2005 Jan; 24(1):62-6. PubMed ID: 15626918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.
    Fu YS; Ro J; Reagan JW; Hall TL; Berek J
    Obstet Gynecol; 1986 Apr; 67(4):478-82. PubMed ID: 3960418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy.
    Vandenput I; Amant F; Vergote I
    Gynecol Oncol; 2005 Sep; 98(3):523; author reply 524-5. PubMed ID: 16054202
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease.
    Kupryjanczyk J; Thor AD; Beauchamp R; Poremba C; Scully RE; Yandell DW
    Mod Pathol; 1996 Mar; 9(3):166-73. PubMed ID: 8685209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
    Wen YH; Yee H; Goswami S; Shukla PS
    Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histologic subtypes and laterality of primary epithelial ovarian tumors.
    Boger-Megiddo I; Weiss NS
    Gynecol Oncol; 2005 Apr; 97(1):80-3. PubMed ID: 15790441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum.
    Seidman JD; Horkayne-Szakaly I; Cosin JA; Ryu HS; Haiba M; Boice CR; Yemelyanova AV
    Gynecol Oncol; 2006 Nov; 103(2):703-8. PubMed ID: 16828848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peritoneal gliomatosis in immature ovarian teratoma].
    Shelekhova KV
    Arkh Patol; 2008; 70(5):34-5. PubMed ID: 19137782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benign and malignant serous and endometrioid epithelium in the omentum.
    Quddus MR; Sung CJ; Lauchlan SC
    Gynecol Oncol; 1999 Nov; 75(2):227-32. PubMed ID: 10525377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.
    Ren J; Peng Z; Yang K
    Gynecol Oncol; 2008 Aug; 110(2):162-7. PubMed ID: 18495223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperplastic mesothelial cells within abdominal lymph nodes: mimic of metastatic ovarian carcinoma and serous borderline tumor--a report of two cases associated with ovarian neoplasms.
    Clement PB; Young RH; Oliva E; Sumner HW; Scully RE
    Mod Pathol; 1996 Sep; 9(9):879-86. PubMed ID: 8878019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.